I tipped this stock exactly a month ago and only managed a 23% gain. I'm tipping it again. I will use the same reasons as last time, but with one addition. A rumour.
BLT are into gene silencing and they have a deal with Axovamt for OPMD. There is a major update due this quarter and it should contain some serious information from preclinical animal trials. It should also contain some new indications to the pipeline. I am expecting them to finally start to show some movement. The SP has slipped back a little but there is little volume.
And now the rumour........
They have a sidelined HBV program which has been awaiting a partner. There are some improved delivery methods that they have been working on. A very distinguished poster has posted about a report (unquoted source, so far) saying that a partnership with Merck is about to be announced. We may see a trading halt because of this rumour. If it's true, expect fireworks.